Atai Beckley Inc.
NASDAQ:ATAIBiotechnology
-$0.06 today
- Market cap
- $2.72B
- Beta
- 1.60
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$2.93
Volume 0.00M
Average 5.68M
ATAI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Atai Beckley Inc.NASDAQ: ATAI
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development growth accelerates
Q2 FY2026 research & development of $28.07M rose 154.5% year over year, ahead of the +47.5% change in trailing-twelve-month research & development. Sequentially, it rose 61.2% from the prior quarter. Over 3 fiscal years it compounded at -10.6% a year.
Context
- Research & development amounted to 1297.7% of revenue in FY2025, down 16553.6 pp from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +154.5% holds above the trailing-twelve-month pace of +47.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 53.06M USD
- Year-over-year change
- -3.5%
- 4-year CAGR
- +2.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 53.06M | -3.5% |
| FY2024 | 2024-12-31 | 54.98M | -11.2% |
| FY2023 | 2023-12-31 | 61.88M | -16.5% |
| FY2022 | 2022-12-31 | 74.15M | +54.8% |
| FY2021 | 2021-12-31 | 47.91M | — |
Research & Development vs competitors
How ATAI compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +47.5% is the 2nd highest of 11, against a peer median of +4.9%.
- Research & development amounts to 1767.0% of revenue for ATAI, versus a peer median of 1577.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $270.72M USD | -4.1% | +2.0% | 2615.7% | |
| LTM Mar 2026 | $255.99M USD | +3.7% | +29.7% | 117.9% | |
| LTM Mar 2026 | €201.11M EUR | +27.4% | +19.9% | 539.2% | |
| LTM Jun 2026 | $175.6M USD | +66.9% | +70.5% | 9222.6% | |
| LTM Mar 2026 | $146.28M USD | -4.6% | -13.1% | — | |
| LTM Jun 2026 | $131.77M USD | +6.1% | -18.7% | 241.4% | |
| LTM Mar 2026 | $116.62M USD | -0.1% | +21.2% | — | |
| LTM Mar 2026 | $100.84M USD | -42.7% | +0.9% | 7756.8% | |
| LTM Sep 2026 | $100.83M USD | +9.7% | -1.1% | — | |
| LTM Sep 2026 | $98.95M USD | +16.0% | +40.4% | — | |
| LTM Jun 2026 | $79.04M USD | +47.5% | -10.6% | 1767.0% | |
| Peer median (excluding ATAI) | — | +4.9% | +10.9% | 1577.4% | |
Competitors are the stored peer set for ATAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 20.38M | 233K | 314K | 308K | 4.09M |
| Cost of Revenue | 47K | 168K | 319K | 473K | 1.01M |
| Gross Profit | 20.33M | 65K | (5K) | (165K) | 3.08M |
| Gross Margin | 99.8% | 27.9% | -1.6% | -53.6% | 75.3% |
| Research & Development | 47.91M | 74.15M | 61.88M | 54.98M | 53.06M |
| Selling, General & Admin | 92.75M | 70.35M | 63.58M | 47.54M | 49.78M |
| Operating Expenses | 140.65M | 144.5M | 125.47M | 102.53M | 102.84M |
| Depreciation & Amortization | 47K | 168K | 319K | 473K | 1.01M |
| EBITDA | (178.19M) | (150.1M) | (39.9M) | (147.33M) | (657.68M) |
| EBITDA Margin | -874.5% | -64419.3% | -12708.3% | -47835.4% | -16084.0% |
| Operating Income | (120.33M) | (144.43M) | (125.47M) | (102.69M) | (99.76M) |
| Operating Margin | -590.5% | -61987.1% | -39958.9% | -33341.2% | -2439.7% |
| Interest Income | 205K | 548K | 1.85M | 778K | 1.48M |
| Interest Expense | 0 | 923K | 2.66M | 3.12M | 1.16M |
| Other Income / Expenses | (57.91M) | (6.76M) | 82.59M | (48.24M) | (560.09M) |
| Income Before Tax | (178.23M) | (151.19M) | (42.88M) | (150.93M) | (659.85M) |
| Pre-Tax Margin | -874.7% | -64887.6% | -13655.7% | -49003.2% | -16137.2% |
| Income Tax Expense | (3.99M) | 6.23M | 1.02M | (881K) | 298K |
| Net Income | (167.81M) | (152.39M) | (40.22M) | (149.27M) | (660.05M) |
| Net Margin | -823.6% | -65401.3% | -12810.2% | -48464.0% | -16142.0% |
| EPS (Basic) | (1.04) | (0.98) | (0.25) | (0.93) | (2.91) |
| EPS (Diluted) | (1.04) | (0.98) | (0.25) | (0.93) | (2.91) |
| Weighted Avg Shares | 160.68M | 155.72M | 158.83M | 160.16M | 226.53M |
| Weighted Avg Shares (Diluted) | 160.68M | 155.72M | 158.83M | 160.16M | 226.53M |
Atai Beckley Inc.
NASDAQ:ATAI
Intrinsic Alpha fair value
Locked
Current Price
$7.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.